Myfortic (enteric-coated mycophenolate sodium) for the treatment of non-infectous intermediate uveitis – a prospective, controlled randomized multicenter trial

Centre for Ophthalmology, University of Tuebingen0 个研究点目标入组 144 人开始时间: 2009年12月2日最近更新: 2017年5月22日

适应症

试验速览

暂无简介。

•Subjects with a documented at least 6 months history of unilateral or bilateral intermediate uveitis either idiopathic or due to non-infectious systemic disease (e.g. sarcoidosis, multiple sclerosis);
•Uveitis has to be considered to be active at the timeoint of enrolment according to at least one of the following criteria:
•oGrade 2+ or higher for vitreous haze
•oGrade 2+ or higher for anterior chamber cells
•oPresence of cystoid macular edema in OCT
•oPresence of retinal vessel leakage in FA
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

发起方

Centre for Ophthalmology, University of Tuebingen